Menopausal hormone therapy and risk of biliary tract cancers: Addressing the ant, not the elephant in the room
Sign Up to like & getrecommendations! Published in 2021 at "Hepatology"
DOI: 10.1002/hep.32254
Abstract: Sex hormones are responsible for multiple physiologic processes by signalling through estrogen (ER) and androgen receptors (AR).(1) ERs and ARs are expressed in liver and biliary tract cells in normal and diseased states in both… read more here.
Keywords: menopausal hormone; biliary tract; hormone therapy; tract ... See more keywords
Menopausal hormone therapy and risk of melanoma: Do estrogens and progestins have a different role?
Sign Up to like & getrecommendations! Published in 2017 at "International Journal of Cancer"
DOI: 10.1002/ijc.30878
Abstract: The association between use of menopausal hormone therapy (HT) and occurrence of skin malignant melanoma (SMM) is controversial. We investigated the issue in a nationwide cohort of 684,696 Norwegian women, aged 45–79 years, followed from… read more here.
Keywords: risk smm; risk; estrogens progestins; smm ... See more keywords
Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish Menopause Society, Sociedad Española de Ginecología y Obstetricia and Sociedad Española de Trombosis y Hemostasia
Sign Up to like & getrecommendations! Published in 2020 at "Maturitas"
DOI: 10.1016/j.maturitas.2020.04.019
Abstract: Abstract COVID-19 is associated with a systemic inflammatory response with activation of coagulation in symptomatic patients. The possibility of coagulopathies in peri- and postmenopausal women taking estrogen therapies makes it necessary to consider antithrombotic strategies,… read more here.
Keywords: espa ola; hormone therapy; sociedad espa; menopausal hormone ... See more keywords
Association between menopausal hormone therapy use and mortality risk: a Swedish population-based matched cohort study
Sign Up to like & getrecommendations! Published in 2022 at "Acta Oncologica"
DOI: 10.1080/0284186x.2022.2033316
Abstract: Abstract Background The net effect of menopausal hormone therapy on the risk of death is understudied, and current evidence is conflicting. Our aim was to investigate the association between menopausal hormones and risk of all-cause,… read more here.
Keywords: menopausal hormone; mortality; hormone therapy; therapy ... See more keywords
Review of menopausal hormone therapy with estradiol and progesterone versus other estrogens and progestins
Sign Up to like & getrecommendations! Published in 2022 at "Gynecological Endocrinology"
DOI: 10.1080/09513590.2022.2118254
Abstract: Abstract Objective: The objective of the present document was to review/summarize reported outcomes compared between menopausal hormone therapy (MHT) containing estradiol (E2) versus other estrogens and MHT with progesterone (P4) versus progestins (defined as synthetic… read more here.
Keywords: versus estrogens; menopausal hormone; progesterone versus; hormone therapy ... See more keywords
Bioidentical menopausal hormone therapy: registered hormones (non-oral estradiol ± progesterone) are optimal
Sign Up to like & getrecommendations! Published in 2017 at "Climacteric"
DOI: 10.1080/13697137.2017.1291607
Abstract: Abstract The many advantages of registered bioidentical sex hormones over registered, conventional, non-bioidentical menopausal hormone therapy (MHT) are considered. The transdermal route of estrogen administration avoids excess venous thromboembolic and ischemic stroke events. There is… read more here.
Keywords: estradiol; bioidentical menopausal; hormone therapy; menopausal hormone ... See more keywords
Menopausal hormone therapy for primary prevention: why the USPSTF is wrong
Sign Up to like & getrecommendations! Published in 2017 at "Climacteric"
DOI: 10.1080/13697137.2017.1362156
Abstract: Abstract The US Preventive Services Task Force (USPSTF) Draft Recommendation statement on Menopausal Hormone Therapy: Primary Prevention for Chronic Diseases, released in May 2017, perpetuates a major disconnect between the primary population affected, women within… read more here.
Keywords: therapy primary; hormone therapy; menopausal hormone;
Cerebrovascular reactivity after cessation of menopausal hormone treatment
Sign Up to like & getrecommendations! Published in 2019 at "Climacteric"
DOI: 10.1080/13697137.2018.1538340
Abstract: Abstract Objective: Women who are currently using menopausal hormone therapy (MHT) have higher cerebrovascular reactivity when compared with postmenopausal women who are not taking MHT; however, the effect of cessation of MHT on cerebrovascular reactivity… read more here.
Keywords: menopausal hormone; reactivity; cerebrovascular reactivity; cessation ... See more keywords
Menopausal hormone therapy: what are the problems in the perception of Chinese physicians?
Sign Up to like & getrecommendations! Published in 2022 at "Climacteric"
DOI: 10.1080/13697137.2022.2058391
Abstract: Abstract Objective This study aimed to investigate Chinese physicians’ perception and attitudes toward menopausal hormone therapy (MHT). Methods This nationwide online survey was conducted in China. Physicians registered in the WeChat groups of the Gynecological… read more here.
Keywords: menopausal hormone; chinese physicians; problems perception; therapy problems ... See more keywords
Patterns of menopausal hormone therapy use and hyperkyphosis in older women
Sign Up to like & getrecommendations! Published in 2018 at "Menopause"
DOI: 10.1097/gme.0000000000001070
Abstract: Objective: Hyperkyphosis, an exaggerated anterior curvature of the thoracic spine, is associated with poor physical function, falls, fractures, and earlier mortality. Low bone mineral density, bone loss, and vertebral fractures are strong risk factors for… read more here.
Keywords: use; adjusted models; menopausal hormone; hormone therapy ... See more keywords
Rethinking Menopausal Hormone Therapy: For Whom, What, When, and How Long?
Sign Up to like & getrecommendations! Published in 2023 at "Circulation"
DOI: 10.1161/circulationaha.122.061559
Abstract: Menopausal hormone therapy (HT) was widely used in the past, but with the publication of seminal primary and secondary prevention trials that reported an excess cardiovascular risk with combined estrogen-progestin, HT use declined significantly. However,… read more here.
Keywords: menopausal; menopausal hormone; rethinking menopausal; hormone therapy ... See more keywords